Submission Details
| 510(k) Number | K933716 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 30, 1993 |
| Decision Date | December 19, 1994 |
| Days to Decision | 507 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K933716 is an FDA 510(k) clearance for the ABBOTT CHAGAS ANTIBODY EIA, a Enzyme Linked Immunosorbent Assay, T. Cruzi (Class I — General Controls, product code MIU), submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on December 19, 1994, 507 days after receiving the submission on July 30, 1993. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3870.
| 510(k) Number | K933716 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 30, 1993 |
| Decision Date | December 19, 1994 |
| Days to Decision | 507 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | MIU — Enzyme Linked Immunosorbent Assay, T. Cruzi |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 866.3870 |